Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 2
2019 1
2020 2
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
BDNF and Tau as biomarkers of severity in multiple sclerosis.
Islas-Hernandez A, Aguilar-Talamantes HS, Bertado-Cortes B, Mejia-delCastillo GJ, Carrera-Pineda R, Cuevas-Garcia CF, Garcia-delaTorre P. Islas-Hernandez A, et al. Among authors: bertado cortes b. Biomark Med. 2018 Jul;12(7):717-726. doi: 10.2217/bmm-2017-0374. Epub 2018 Jun 5. Biomark Med. 2018. PMID: 29865854
Clinical practice patterns in multiple sclerosis management: Mexican consensus recommendations.
Skromne-Eisenberg E, Treviño-Frenk I, Llamosa García Velázquez GL, Quiñones-Aguilar S, Rivas-Alonso V, Maza-Flores M, Macías-Islas MÁ, Llamas-López L, González-Amezquita V, León-Jiménez C, Medina-López Z, Ortiz-Maldonado JF, Santos-Diaz MA, Bertado-Cortés B, Flores-Rivera JJ, Ordóñez-Boschetti L. Skromne-Eisenberg E, et al. Among authors: bertado cortes b. Mult Scler Relat Disord. 2021 Aug;53:103053. doi: 10.1016/j.msard.2021.103053. Epub 2021 May 30. Mult Scler Relat Disord. 2021. PMID: 34139461
Demographic and clinical characterization of multiple sclerosis in Mexico: The REMEMBer study.
Bertado-Cortés B, Venzor-Mendoza C, Rubio-Ordoñez D, Pérez-Pérez JR, Novelo-Manzano LA, Villamil-Osorio LV, Jiménez-Ortega MJ, Villalpando-Gueich ML, Sánchez-Rosales NA, García-Talavera V. Bertado-Cortés B, et al. Mult Scler Relat Disord. 2020 Nov;46:102575. doi: 10.1016/j.msard.2020.102575. Epub 2020 Oct 9. Mult Scler Relat Disord. 2020. PMID: 33296973
Corrigendum to demographic and clinical characterization of multiple sclerosis in Mexico: The Remember study multiple sclerosis and related disorders volume (2020) MSARD-D-20-00380R3 [201111-021909].
Bertado-Cortés B, Venzor-Mendoza C, Rubio-Ordoñez D, Pérez-Pérez JR, Novelo-Manzano LA, Villamil-Osorio LV, Jiménez-Ortega MJ, Villalpando-Gueich ML, Sánchez-Rosales NA, García-Talavera V. Bertado-Cortés B, et al. Mult Scler Relat Disord. 2021 Feb;48:102679. doi: 10.1016/j.msard.2020.102679. Epub 2020 Dec 16. Mult Scler Relat Disord. 2021. PMID: 33593589 No abstract available.
Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: Randomized, double-blind, placebo-controlled clinical trial. Preliminary report.
Arreola-Mora C, Silva-Pereyra J, Fernández T, Paredes-Cruz M, Bertado-Cortés B, Grijalva I. Arreola-Mora C, et al. Among authors: bertado cortes b. Mult Scler Relat Disord. 2019 Feb;28:117-124. doi: 10.1016/j.msard.2018.12.026. Epub 2018 Dec 19. Mult Scler Relat Disord. 2019. PMID: 30593980 Clinical Trial.